Viamonte, Manuel A.
Filipp, Stephanie L.
Zaidi, Zara
Gurka, Matthew J.
Byrne, Barry J.
Kang, Peter B. http://orcid.org/0000-0002-4270-7325
Funding for this research was provided by:
Sanofi
Article History
Received: 25 January 2021
Revised: 1 April 2021
Accepted: 20 April 2021
First Online: 11 May 2021
Compliance with ethical standards
:
: Dr MAV was supported in part by an unrestricted educational fellowship from Sanofi Genzyme. Ms SLF reports no disclosures. Dr ZZ reports no disclosures. Dr MJG reports no disclosures. Dr BJB is a member of the Pompe Registry Scientific Advisory Board, and has received grant support from Sanofi Genzyme and Amicus Therapeutics. Dr PBK was the uncompensated grantee of the unrestricted fellowship from Sanofi Genzyme that supported Dr MAV. He has served as a consultant for AveXis and ChromaDex, and on an advisory board for Sarepta Therapeutics. This study was supported in part by an unrestricted educational fellowship from Sanofi Genzyme (2015–2017). Neither Sanofi Genzyme nor any individuals or organizations employed/contracted by Sanofi Genzyme participated in study design, data collection, data analysis, drafting of the paper writing, editing of the paper, or decision to submit this paper for publication.